Upgrade to SI Premium - Free Trial

Alexion Pharmaceuticals (ALXN) PT Raised to $149 at Wedbush

October 23, 2019 1:51 PM

Wedbush analyst Laura Chico raised the price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $149.00 (from $146.00) while maintaining a Outperform rating.

Categories

Analyst PT Change

Next Articles